GYRODYNE LLC
GYRONASDAQπ #4831 by market capUS Equity
$4.48βΌ $0.39 (β8.10%)
Market closed Β· at closeTrack GYRO
Get earnings, price moves & breaking news on Telegram
24hβΌ 8.1%
7dβΌ 8.1%
14dβΌ 8.1%
30dβΌ 11.3%
ytdβΌ 53.5%
1yβΌ 54.8%
π¦Market Cap
$10M
Small Cap
πRevenue Growth (YoY)
62.8%
High Growth
πGross Margin
46.5%
Healthy
π΅FCF Margin
3062.3%
Strong
βοΈP/S Ratio
1.8x
Cheap
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $4.48 β $4.48
- 52-Week Range
- $4.09 β $10.01
- Volume (shares)
- 100
- Avg Volume (shares)
- β
- Shares Outstanding
- 2.2M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- 187.9
- P/S Ratio
- 1.8x
- EPS (TTM)
- $0.04
- Dividend Yield
- β
- Dilution (1yr)
- +0.0%
GYRODYNE LLC
GYROFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β² +0.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
27.5%βΌ β42.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
$5Kβ² +0.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
1.5Mβ² +0.0% YoY
About GYRODYNE LLC
Gyrodyne, LLC is a real estate firm engaged in the acquisition, leasing, and oversight of various commercial properties. A core principle of their business model is a strong commitment to customer service across all aspects of their property holdings and management activities. While historically operating primarily in Long Island, Gyrodyne has substantially expanded its footprint, now managing a diverse portfolio spanning the entire East Coast, with a notable specialization in medical office spaces.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.